Has Jonathan Rehfuss, MD received payments from drug or device companies?

Yes. Drug and device makers reported $7,992 in general payments to Jonathan Rehfuss, MD across 97 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jonathan Rehfuss, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jonathan Rehfuss, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jonathan Rehfuss, MD

Vascular Surgery · N Charleston, SCNPI 1023370863

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (50.1%), grants and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 67.2% of it on its own, with 20 other manufacturers making up the rest. That places this record below the midpoint for vascular surgery clinicians in SC, where the typical reported total is $7,261.

$7,992in general payments, 2019–2025

Across 97 payments — averaging $82.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$5K
W. L. Gore & Associates, Inc.$578
Endologix LLC$442
Shockwave Medical, Inc$238
Silk Road Medical, Inc.$201
Stryker$198
plus $963 from 15 others

What the payments were for

Grants$2,50031%
Travel & lodging$78410%
Food & beverage$4,00350%
Education$7059%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	44	$5,372
W. L. Gore & Associates, Inc.	9	$578
Endologix LLC	4	$442
Shockwave Medical, Inc	3	$238
Silk Road Medical, Inc.	2	$201
Stryker	4	$198
Siemens Medical Solutions USA, Inc.	2	$188
Lemaitre Vascular, Inc.	4	$178
Pacira Pharmaceuticals Incorporated	1	$110
Polynovo North America LLC	2	$78
Boston Scientific	2	$75
Smith+Nephew	3	$58
Solventum Corporation	2	$47
E.r. Squibb & Sons, L.L.C.	3	$47
Johnson & Johnson	3	$42
Angiodynamics, Inc.	3	$41
Cashflow Solutions, LLC	2	$26
Tactile Systems Technology Inc	1	$22
KCI USA, Inc.	1	$21
Edwards Lifesciences	1	$16
Paratek Pharmaceuticals, Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Endurant$2,500
ELLIPSYS VASCULAR ACCESS SYSTEM$717
Ovation iX Iliac Stent Graft$363
AFX2 Bifurcated Endograft System$363
ENROUTE Transcarotid Neuroprotection System$177
ENROUTE Transcarotid Stent$177
Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$168
Artis icono floor$161
HawkOne$159
GORE VIABAHN VBX Balloon Expandable Endo$149
GORE EXCLUDER AAA Endoprosthesis$148
Conformable TAG Thoracic Endoprosthesis$120
TurboHawk$111
EXPAREL$110

How this compares

$7,992 in reported general payments places this provider in the 50th percentile of 99 vascular surgery providers in South Carolina.

See all vascular surgery providers in South Carolina →

Medicare billing

Part B allowed, 2024

$252,665

Medicare patients

1,422

Services billed

2,493

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	33	$25,595
ClopidogrelClopidogrel Bisulfate	37	$372
Cilostazol	15	$371
Atorvastatin Calcium	15	$216
Oxycodone Hcl	31	$103
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	13	$40
Tramadol Hcl	15	$34
Diazepam	21	$9

Paid to pharmacies, not to this prescriber.

Other vascular surgery in N Charleston

John RossOrangeburg$847K
David DeatonColumbia$609K
Mathew WoosterWest Columbia$443K
Sagar GandhiGreenville$236K
Ravi VeeraswamyCharleston$164K
Gerald FortunaWest Columbia$143K
Kristian HochbergCharleston$106K
Joseph BlasGreenville$101K
Thomas ApplebyNorth Charleston$89K
Zachary ArthursCharleston$84K

See the full list for South Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →